KISS
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Nov 2023)
What this means for you
This application is over — abandoned 20 Nov 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97279990
- Mark type
- Stylized text
- Filed
- 23 Feb 2022
- Published for opposition
- 21 Feb 2023
- Abandoned
- 20 Nov 2023
- Attorney of record
- Bruce S. Londa
Goods and services
- Class 005 — Pharmaceuticals: (Based on 44(e)) sterile implantable products as medicated fluid administrated by injection for filling wrinkles, fine lines, skin depressions, all being dermal fillers; (Based on Intent to Use) dermatological and pharmaceutical products as medicated fluid and lotions administrated by injection for filling wrinkles, fine lines, skin depressions for modeling, increasing volume in the face or any other part of the body, for moisturizing the skin and mucous membranes, for increasing lip volume; anesthetics for surgical use; injectable dermal fillers; (Based on 44(e)) implantable sterile products being dermal fillers for smoothing wrinkles, fine lines, skin depressions and increasing the volume of the lips
Owner
- TEOXANE S.A., Geneva, CH
- TEOXANE S.A., Geneva, CH
Prosecution history
- 20 Nov 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Nov 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Apr 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Feb 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Feb 2023 — PUBLISHED FOR OPPOSITION
- 01 Feb 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Jan 2023 — ELECTRONIC RECORD REVIEW COMPLETE
- 06 Jan 2023 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 02 Jan 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Nov 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Nov 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Nov 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Oct 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Oct 2022 — NON-FINAL ACTION E-MAILED
- 12 Oct 2022 — NON-FINAL ACTION WRITTEN